Shalini Sharp, CFO & Senior Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 4,000 shares at $44.82 ($179K) on 2014-12-18, disclosed to the SEC on 2014-12-22.
Scheduled sale ($179k) by CFO & Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |